Cancer of other lymphoid, histiocytic tissue (UKB)

Model details

PRS IDprsweb-phecode202-gwas-catalog-r2019-05-03-x202-pt-ukb-20200608

Legacy IDPRSWEB_PHECODE202_GWAS-Catalog-r2019-05-03-X202_PT_UKB_20200608

Legacy modelP&T

# SNPs5

Discovery GWAS trait/source GWAS Catalog (2019-05-03)

Genome buildGRCh37/hg19

Tuning parameterP<=5e-07

Reference Publication PubMed search: 25569183, 30305637

Last updated2020-06-08

Evaluation details

Evaluation cohortUK Biobank

Evaluation trait Marginal zone lymphoma;Waldenström macroglobulinemia / lymphoplasmacytic lymphoma
202

Trait typeBinary

SexBoth

Cases1143

Controls11478

PRS performance

P value1.7e-7

Pseudo-R²0.001

Brier score0.082

AAUC0.490

AAUC CI0.476-0.505

Percentile effect metricOR

Top percentile	OR	95% CI
1%	1.97	1.25-3.12
2%	1.73	1.28-2.34
5%	1.46	1.15-1.85
10%	1.35	1.13-1.62
25%	1.34	1.17-1.52

How to use this score page

Start with P value and the main performance metrics above to judge whether this model is useful in this cohort.
Use the top-percentile rows to see how strongly the score separates the upper PRS tail.
Use the linked PheWAS follow-up after the primary-trait evaluation, not as a substitute for it.

Flag guide: nominally significant passed the preserved release's nominal threshold; reversed effect means the observed direction ran opposite to the expected effect direction in the preserved evaluation.

Files and next steps

Start with the interactive PheWAS page to inspect notable associations for this score. Use the PRS PheWAS file for the full phenome scan, the exclusion PheWAS file for secondary associations after removing primary or related trait cases, and the weight link when you need the score construction itself. See the Method page for metric definitions and cohort context.